title: Evaluation of children with multiple endocrine neoplasia type IIb following thyroidectomy.
abstract: Medullary thyroid carcinoma (MTC) develops in all patients with multiple endocrine neoplasia type IIb (MEN IIb), a rare syndrome that either occurs sporadically or is inherited in an autosomal dominant pattern. The MTC in patients with MEN IIb has been reported to be biologically aggressive with onset at a young age and rapid progression as evidenced by widespread metastases and death, frequently in the teenage years. Seven children, aged 2 to 11 years (mean, 7 years), from three kindreds with MEN IIb were evaluated for evidence of tumor recurrence 3 to 10 years following thyroidectomy. In one child, age 11, a thyroid mass was palpable preoperatively. However, in the remaining six children (aged 2 to 10 years), the diagnosis of MTC was established by an increased concentration of plasma calcitonin (CT), either basally or following pentagastrin (Pg) stimulation. All patients underwent total thyroidectomy with removal of central lymph nodes from the neck. At the time of surgery, six children were found to have bilateral macroscopic MTC, five without and one with cervical metastases. One child (age 2 years) had C-cell hyperplasia, a premalignant precursor of MTC. Currently, five of the seven children are without evidence of recurrent disease clinically and have normal plasma CT levels (less than 0.3 ng/mL) following calcium (Ca) and Pg stimulation 3, 3, 10, 10, and 10 years after thyroidectomy. Two of the seven children have biochemical evidence of residual MTC.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Surgery, Washington University School of Medicine, St Louis, MO.
authors.forename: R A
authors.initials: RA
authors.lastname: Decker
authors.forename: W M
authors.initials: WM
authors.lastname: Toyama
authors.forename: L W
authors.initials: LW
authors.lastname: O'Neal
authors.forename: R L
authors.initials: RL
authors.lastname: Telander
authors.forename: S A
authors.initials: SA
authors.lastname: Wells
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood; D002116:Calcitonin / Q000097:blood; D002277:Carcinoma / Q000453:epidemiology / Q000235:genetics / Q000601:surgery*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009377:Multiple Endocrine Neoplasia / Q000235:genetics / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D010375:Pedigree; D013964:Thyroid Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000601:surgery*; D013965:Thyroidectomy; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor; D002116:Calcitonin